术前口服类固醇与抗炎药对下颌磨牙不可逆性牙髓炎下牙槽神经阻滞麻醉成功率的影响:双盲随机临床试验
这项双盲随机试验将184例症状性不可逆性牙髓炎下颌磨牙患者随机分为泼尼松龙、地塞米松、酮咯酸和安慰剂四组(每组46例),在行下牙槽神经阻滞前60分钟口服给药。结果显示四组麻醉成功率分别为60.86%、65.21%、56.52%和21.73%,三种药物均较安慰剂显著提高成功率,但三药之间无显著差异。作者认为术前口服酮咯酸、地塞米松或泼尼松龙可能提高下牙槽神经阻滞的麻醉效果。
要点
- 术前60分钟口服泼尼松龙、地塞米松或酮咯酸均较安慰剂显著提高下牙槽神经阻滞成功率。
- 三种药物之间麻醉成功率无统计学显著差异。
- 酮咯酸组1例报告胃炎,地塞米松组和泼尼松龙组未报告不良反应。
核心结论
- 术前口服酮咯酸、地塞米松或泼尼松龙可能提高症状性不可逆性牙髓炎下颌磨牙下牙槽神经阻滞的麻醉效果。
研究设计与样本
- 双盲随机临床试验,纳入184例确诊为症状性不可逆性牙髓炎的下颌磨牙患者,随机分为泼尼松龙组、地塞米松组、酮咯酸组和安慰剂组,每组46例。
- 各组在行下牙槽神经阻滞前60分钟口服相应药物,确认唇部麻木及连续两次电活力测试阴性后开始开髓。
- 采用单因素方差分析比较定量变量,卡方检验比较分类变量,二元逻辑回归分析年龄、术前疼痛和术前用药的关系。
主要发现
- 术前口服地塞米松、酮咯酸、泼尼松龙和安慰剂的下牙槽神经阻滞成功率分别为60.86%、65.21%、56.52%和21.73%。
- 与安慰剂相比,泼尼松龙、地塞米松或酮咯酸预处理均显著提高下牙槽神经阻滞成功率。
- 泼尼松龙、地塞米松和酮咯酸三组之间无统计学显著差异。
- 酮咯酸组1例报告胃炎,地塞米松组和泼尼松龙组未报告不良反应。
临床怎么用
- 作者认为,术前口服酮咯酸、地塞米松或泼尼松龙可能提高症状性不可逆性牙髓炎下颌磨牙下牙槽神经阻滞的麻醉效果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: This randomized double-blinded trial aimed to compare the anesthetic success of inferior alveolar nerve blocks (IANBs) with 2% lidocaine in mandibular molars with symptomatic irreversible pulpitis (SIP) after oral premedication of prednisolone, dexamethasone, and ketorolac with placebo. METHODS: One hundred eighty-four patients diagnosed with SIP in mandibular molars randomly received prednisolone, dexamethasone, ketorolac, or placebo (n = 46 each) 60 minutes before the administration of an IANB. The access cavity preparation was initiated after successfully confirming lip numbness and two consecutive negative responses to electric pulp testing. The success of the anesthesia was clinically confirmed when pain was absent during the endodontic access or instrumentation. A one-way analysis of variance test was used to compare quantitative variables among the groups, and chi-square tests were used for comparing categorical variables. Binary logistic regression was performed to analyze the relationship of age, preoperative pain, and preoperative medications. RESULTS: When premedicated with oral dexamethasone, ketorolac, prednisolone, and placebo, the success rate of IANB was determined to be 60.86 %, 65.21 %, 56.52 %, and 21.73 %, respectively. Compared to the placebo, the success rate of IANB was significantly increased when patients were premedicated with prednisolone, dexamethasone, or ketorolac. However, there were no statistically significant differences among prednisolone, dexamethasone, and ketorolac. One individual in the ketorolac group reported gastritis, whereas no adverse effects were reported in the dexamethasone or prednisolone groups. CONCLUSIONS: Preoperative use of oral ketorolac, dexamethasone, or prednisolone may increase the anesthetic efficacy of IANB in mandibular molars with SIP.
引用
- Hegde V, Shanmugasundaram S, Shaikh S, et al. Effect of Preoperative Oral Steroids in Comparison to Anti-inflammatory on Anesthetic Success of Inferior Alveolar Nerve Block in Mandibular Molars with Symptomatic Irreversible Pulpitis-A Double-blinded Randomized Clinical Trial. J Endod. 2023. PMID: 36736586. doi:10.1016/j.joen.2023.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。